THE INDICATIONS FOR ABLATING NORMAL THYROID TISSUE WITH 131I IN DIFFERENTIATED THYROID CANCER
- 1 July 1985
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 23 (1) , 81-86
- https://doi.org/10.1111/j.1365-2265.1985.tb00186.x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Papillary thyroid carcinoma: A 10 year foliow-up report of the impact of therapy in 576 patientsThe American Journal of Medicine, 1981
- Thyroid cancer: Prognosis in 469 patientsBritish Journal of Surgery, 1979
- A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative groupPublished by Elsevier ,1979
- SERUM THYROGLOBULIN IN THE DIAGNOSIS AND MANAGEMENT OF THYROID CARCINOMAClinical Endocrinology, 1979
- The treatment of thyroid carcinoma with radioactive iodineSeminars in Nuclear Medicine, 1978
- Whole-body scanning and131I therapy in the management of thyroid carcinomaThe British Journal of Radiology, 1972
- Thyroid carcinoma: Pathologic classification with data on prognosisSeminars in Nuclear Medicine, 1971
- Radioiodine therapy of thyroid cancerSeminars in Nuclear Medicine, 1971
- Treatment of Thyroid CancerPublished by American Medical Association (AMA) ,1970
- Endocrine Dependency of Papillary Carcinomas of the ThyroidPublished by American Medical Association (AMA) ,1966